Shalabh Gupta is the founder of Unicycive Therapeutics. Latest round: IPO. Based in Palo Alto, California.
Shalabh Gupta is the Founder, Chairman, and CEO of Unicycive Therapeutics, a biopharmaceutical company specializing in kidney disease treatments. He founded the company in January 2016 and successfully guided it to become a publicly traded entity. Gupta's work focuses on developing novel therapies for chronic kidney disease and acute kidney injury.
Full founder directory · Investor directory · Company funding database · Fundraising library